Pre-operative breast MRI in women with recently diagnosed breast cancer - Where to next?

Breast

Volumn 19, Issue 1, 2010, Pages 1-2

  Houssami, N ^a   Morrow, M ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER RECURRENCE; DISEASE FREE SURVIVAL; EDITORIAL; HUMAN; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT DECISION MAKING; PATIENT SELECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; BREAST TUMOR; CANCER STAGING; DRUG CONTRAINDICATION; FEMALE; LABORATORY DIAGNOSIS; METHODOLOGY; PATHOLOGY; PREOPERATIVE CARE; PREOPERATIVE PERIOD; RISK ASSESSMENT; WOMEN'S HEALTH;

BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; NEOPLASM STAGING; PREOPERATIVE CARE; PREOPERATIVE PERIOD; RISK ASSESSMENT; WOMEN'S HEALTH;

EID: 77951933525     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2009.11.002     Document Type: Editorial

References (19)

1. Houssami N., Hayes D.F. Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer?. CA: A Cancer Journal for Clinicians 2009, 59:290-302.
2. Morrow M. Magnetic resonance imaging in the breast cancer patient: curb your enthusiasm. Journal of Clinical Oncology 2008, 26:352-353.
3. Liberman L. Breast MR imaging in assessing extent of disease. Magnetic Resonance Imaging Clinics of North America 2006, 14:339-349.
4. Kuhl C., Kuhn W., Braun M., Schild H. Pre-operative staging of breast cancer with breast MRI: one step forward, two steps back?. Breast 2007, 16(Suppl. 44).
5. Schnall M. MR imaging evaluation of cancer extent: is there clinical relevance?. Magnetic Resonance Imaging Clinics of North America 2006, 14:379-381.
6. Lehman C.D., Gatsonis C., Kuhl C.K., Hendrick R.E., Pisano E.D., Hanna L., et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. New England Journal of Medicine 2007, 356:1295-1303.
7. Solin L.J., Orel S.G., Hwang W.T., Harris E.E., Schnall M.D. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. Journal of Clinical Oncology 2008, 26:386-391.
8. Houssami N., Ciatto S., Macaskill P., Lord S.J., Warren R.M., Dixon J.M., et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. Journal of Clinical Oncology 2008, 26:3248-3258.
9. Bleicher R.J., Ciocca R.M., Egleston B.L., et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. Journal of the American College of Surgeons 2009, 294(209):180-187.
10. Katipamula R., Degnim A.C., Hoskin T., Boughey JC., Loprinzi C., Grant C.S., et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. Journal of Clinical Oncology 2009, 27:4082-4088.
11. Sardanelli F. Overview of the role of pre-operative breast MRI in the absence of evidence on patient outcomes. Breast 2010, 19:395-398.
12. Solin L.J. Counterview: pre-operative MRI is not recommended for all patients with newly diagnosed breast cancer. Breast 2010, 19:399-401.
13. McCaffery K.J., Jansen J. Pre-operative MRI for women with newly diagnosed breast cancer: perspectives on clinician and patient decision-making when evidence is uncertain. Breast 2010, 19:402-404.
14. Bilimoria K.Y., Cambic A., Hansen N.M., Bethke K.P. Evaluating the impact of preoperative breast magnetic resonance imaging on the surgical management of newly diagnosed breast cancers. Archives of Surgery 2007, 445(142):441-445.
15. Sorbero M.E., Dick A.W., Beckjord E.B., Ahrendt G. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Annals of Surgical Oncology 2009, 16:1597-1605.
16. Turnbull L. Magnetic resonance imaging in breast cancer: results of the COMICE trial. Breast Cancer Research 2008, 10(Suppl. 3):P10.
17. Peters N., Borel Linkes I., Mali W., van den Bosch M., Storm R.K., Plaisier P.W., et al. Breast MRI in non-palpable breast lesions: a randomized trial with diagnostic and therapeutic outcome - MONET - study. Trial 2007, 8:40.
18. Nguyen P.L., Taghian A.G., Katz M.S., Niemierko A., Abi Raad R.F., Boon W.L., et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. Journal of Clinical Oncology 2008, 26:2373-2378.
19. Kyndi M., Sorensen F.B., Knudsen H., Overgaard M., Nielsen H.M., Overgaard J. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. Journal of Clinical Oncology 2008, 26:1419-1426.